Hudson Laerte Machado Miranda

Hudson Laerte Machado Miranda

Auto-generated profile, based on publicly available information

Hudson Laerte Machado Miranda

Hospital Samel, Manaus, AM - Brasil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2021 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
SBSilvio Henrique Barberato
Silvio Henrique Barberato
RBRafael Borsoi
Rafael Borsoi
FRFabio Roston
Fabio Roston
HMHudson Laerte Machado Miranda
Hudson Laerte Machado Miranda
PPPedro Patriota
Pedro Patriota
MFMiguel Morita Fernandes-Silva
Miguel Morita Fernandes-Silva
Introdução A doença do coronavírus-2019 (COVID-19), causada pelo vírus da síndrome respiratória aguda grave coronavírus 2 (SARS-CoV-2), pode resultar em insuficiência respiratória grave e lesão cardíaca aguda. Disfunção cardíaca e/ou doença cardiovascular (DCV) prévia em pacientes com COVID-19 estão associadas a pior prognóstico. A ecocardiografia transtorácica (ETT) tem um papel central no manejo dos pacientes, pois fornece uma avaliação crucial das anormalidades da função e estrutura cardíacas que impactam em seu prognóstico e tratamento. Estudos relataram taxas variadas de disfunção [...] Introdução A doença do coronavírus-2019 (COVID-19), causada pelo vírus da síndrome respiratória aguda grave coronavírus 2 (SARS-CoV-2), pode resultar em insuficiência respiratória grave e lesão cardíaca aguda. Disfunção cardíaca e/ou doença cardiovascular (DCV) prévia em pacientes com COVID-19 estão associadas a pior prognóstico. A ecocardiografia transtorácica (ETT) tem um papel central no manejo dos pacientes, pois fornece uma avaliação crucial das anormalidades da função e estrutura cardíacas que impactam em seu prognóstico e tratamento. Estudos relataram taxas variadas de disfunção

1 April 2021 in European Heart Journal: Acute Cardiovascular Care
Verified
Journal Article
Open access
PDF file
IAI Almeida
I Almeida
MSM Santos
M Santos
HSHelder Santos
Helder Santos
HMH Miranda
H Miranda
JCJ Chin
J Chin
LAL Almeida
L Almeida
Funding Acknowledgements: Type of funding sources: None. OnBehalf: Portuguese Registry of Acute Coronary Syndromes (ProACS) Introduction: Although brain natriuretic peptides (BNP) has been primarily identified in brain tissue, its clinical application is primarily related to cardiac disease, namely heart failure. The current information on this natriuretic peptide in cerebrovascular disease is limited, however some studies performed showed an acute elevation of BNP during the acute phase of ischemic stroke. Objective: Evaluation of prognostic value of BNP in the occurrence of in-hospital ischemic stroke in patients admitted with ST elevation myocardial infarction (STEMI). Material and methods: Retrospective analysis of patients´ data admitted with STEMI at multicentric registry between October 2010 and January 2019. Patients were divided into two groups: group 1 – patients who suffered an ischemic stroke (0.8%) and group 2 – without stroke (99.2%). Demographic and clinical characteristics were compared. A logistic regression was performed to evaluate prognostic value of BNP in the occurrence of in-hospital stroke and cardiovascular events. Results: Admitted 1650 patients with STEMI. There was no statistically significant difference between mean age in both groups (mean age 64 ± 13 years, p 0.122) and most patients were male (75.4%). A higher percentage of group 1 patients had a previous diagnosis of stroke/ transitory ischemic accident (28.6 vs 5.4%, p 0.006) but there was no significant differences regarding the percentages of previous arterial hypertension, diabetes, dyslipidaemia neither peripheral vascular disease. Mean values of BNP at admission were higher in group 1: 839 ± 1088 vs 333 ± 639 pg/ml (p 0.04). All patients were submitted to coronary angiography, without evidence of significant differences regarding severity of coronary disease. In group 1 patients mean left ventricle ejection fraction (LVEF) during hospitalization was lower: 43 ± 11 vs 53 ± 13 %, p 0.005. Logistic regression identified as prognostic factors of in-hospital ischemic stroke: previous stroke/ transitory ischemic accident (p 0.007), dementia (p 0.005) or thoracic pain at STEMI presentation (p 0.005). Although patients with higher levels of BNP had suffered more stroke (0.5% in group with BNP < 100pg/ml; 0.6% in group with 100 ≤ BNP < 400 pg/ml; and 2.0% in group with BNP ≥ 400 pg/ml), BNP did not show to be predictor of stroke occurrence in this context (p 0.862). Conclusion: Although patients with higher levels of BNP had suffered more stroke, BNP did not show to be predictor of stroke occurrence in patients admitted with STEMI.